At this year’s annual meeting of health-care executives and investors in San Francisco, an industry criticized over the high prices of its drugs got a taste of its own medicine. The four-day J.P. Morgan Healthcare Conference, known more for speed-date meetings and deals than actual presentations, this year packed thousands of investors, bankers and executives into the rain-soaked Union Square neighborhood.